ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 560

Purified IgG From Patients With Systemic Lupus Erythematosus Enhances Apoptosis In Neonatal Rat Cardiomyocytes Exposed To Simulated Myocardial Ischaemic/Reperfusion Injury

Lauren Bourke1, James McCormick2, Vera Ripoll3, Charis Pericleous4, Anna Radziszewska5, Anastasis Stephanou6 and Yiannis Ioannou7, 1Centre for Rheumatology Research, University College London, London, United Kingdom, 2Clinical & Molecular Genetics Unit, University College London, London, United Kingdom, 3Centre for Rheumatology Research, Division of Medicine, University College London, London, United Kingdom, 4Centre for Rheumatology, Division of Medicine, Centre for Rheumatology, University College London, London, United Kingdom, 5The Rayne Institute, Arthritis Research UK Centre for Adolescent Rheumatology at University College London, Great Ormond Street Hospital and UCLH, University College London, London, United Kingdom, 6Medical and Molecular Biology Unit (MMBU), University College London, London, United Kingdom, 7Arthritis Research UK Centre for Adolescent Rheumatology at University College London, Great Ormond Street Hospital and UCLH, University College London, London, United Kingdom

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Apoptosis, autoantibodies, cardiovascular disease and immunoglobulin (IG)

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose:

A significant amount of myocardial damage during a myocardial infarction (MI) occurs during the reperfusion stage which is known as ischaemic reperfusion (I/R) injury and can account for up to 50% of cell death. Systemic Lupus Erythematosus (SLE) is a condition associated with a high burden of cardiovascular morbidity and mortality, when compared to the matched healthy population. Patients with SLE have circulating autoantibodies which have been linked to an increased risk of suffering an MI. Studies performed by other groups have shown accelerated I/R injury in other systems such as mesenteric I/R injury in a lupus mouse model, however to date there has been no research focusing on the heart. The purpose of this study is to assess I/R injury in the presence of polyclonal IgG from patients with SLE in an in vitro model of simulated myocardial I/R injury in neonatal rat cardiomyocytes.

Methods:

Polyclonal IgG was isolated by protein G purification from serum of patients with SLE (n=23) and healthy controls (n=11) which were age and gender matched. Endotoxin was removed using Detoxi-Gel columns to a level below 0.225 endotoxin U/mL. It was observed that cells treated with LPS at this level did not have altered caspase-3 cleavage. Fetal calf serum used in the buffers was  also heat inactivated to remove complement mediated mechanisms. We utilised an established in vitro model of anoxia/reoxygenation to I/R injury. Cardiomyocytes were isolated from 1-2 day old rat pups and when beating synchronously were treated with 500 µg/ml polyclonal IgG from each group and the following day exposed to simulated I/R injury for 4hr in a hypoxic chamber (argon, 5% CO2) followed by 4hr of reoxygenation. Apoptosis was measured by assessment of caspase-3 cleavage using immunoblot.

Results:

In cells exposed to simulated I/R injury caspase-3 cleavage was not significantly increased in the presence of IgG from healthy volunteers (mean increase in caspase-3 cleavage of cells treated with healthy control IgG  above untreated cell baseline – 12.28% ± SD 26.01, n=11). However, in the presence of IgG from patients with SLE, caspase-3 cleavage was increased by 54.79% (±SD 28.9, n=23) above untreated cell baseline and therefore significantly increased in comparison to healthy controls (p=0.0016). The effect observed with IgG from SLE patients was not altered when serum used in the buffers was heat inactivated suggesting a non-complement mediated mechanism.  

Conclusion: In this in vitro simulated I/R injury model IgG purified from patients with SLE enhanced I/R injury as assessed by caspase-3 cleavage. This novel pathogenic role of these antibodies will now be tested in vivo to validate this finding and explore potential mechanisms of action.


Disclosure:

L. Bourke,
None;

J. McCormick,
None;

V. Ripoll,
None;

C. Pericleous,
None;

A. Radziszewska,
None;

A. Stephanou,
None;

Y. Ioannou,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/purified-igg-from-patients-with-systemic-lupus-erythematosus-enhances-apoptosis-in-neonatal-rat-cardiomyocytes-exposed-to-simulated-myocardial-ischaemicreperfusion-injury/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology